HemoPalm

HemoPalm is a Canadian in vitro diagnostics and point-of-care testing company formed in 2019 as a wholly owned subsidiary of Relay Medical, now Scryb. The company is developing portable blood analysis systems and single-use cartridge-based tests that combine optical CO-oximetry with electrochemical biosensor measurement of blood gases and electrolytes. Its product family has included the core HemoPalm blood gas platform and HemoPalm-CX, a compact CO-oximetry device designed to measure multiple hemoglobin species directly from whole blood without sample preprocessing. The platform has also been described as supporting bilirubin testing and cloud-based connectivity for hospital workflow integration. Based on the publicly available information, HemoPalm appears to be an early-stage diagnostics/device venture rather than a therapeutics developer.